CHARNWOOD MOLECULAR
Charnwood Molecular providing medicinal and synthetic chemistry services to the global pharmaceutical, biotechnology and chemical industries. The cornerstone of our success is regular and open communication with our clients, the highest integrity in our business relationships, high quality yet cost-effective services, and the flexibility that we offer to always meet our clients’ demands – we can undertake projects from one week in duration to multi-year, multi-FTE collaborations.
CHARNWOOD MOLECULAR
Industry:
Biotechnology
Founded:
1998-01-01
Address:
Loughborough, Leicestershire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.charnwood-molecular.com
Total Employee:
11+
Status:
Active
Contact:
+44 (0) 1509 232007
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Google Tag Manager WordPress Domain Not Resolving Apache Sitelinks Search Box
Current Employees Featured
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-06-21 | Aurelia Bioscience | Aurelia Bioscience acquired by Charnwood Molecular | N/A |
Official Site Inspections
http://www.charnwood-molecular.com Semrush global rank: 4.09 M Semrush visits lastest month: 2.98 K
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 3.33.251.168
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Charnwood Molecular"
Charnwood Discovery the New Name for Charnwood …
Sep 20, 2023 Charnwood Molecular, a leading drug discovery CRO that specializes in enhancing the experience and success of complex drug discovery for clients globally, is excited to announce a significant milestone in its history. …See details»
Drug Discovery Services CRO | Charnwood Discovery
Charnwood Discovery (part of Concept Life Sciences) Frith Knoll Road, Chapel-en-le-Frith, High Peak, SK23 0PG, United Kingdom +44 (0) 1298 816700. [email protected]. Drug discovery solutions. Integrated Drug Discovery; Bioscience; Discovery Chemistry; ADME / …See details»
Charnwood Molecular - Crunchbase Company Profile …
Charnwood Molecular providing medicinal and synthetic chemistry services to the global pharmaceutical, biotechnology and chemical industries. The …See details»
Troubled Loughborough life sciences firm sold
Nov 4, 2024 As TheBusinessDesk.com exclusively revealed on October 24, Charnwood Molecular and Aurelia Bioscience, which trade as Charnwood Discovery, both filed a second notice of intention (NOI) to appoint ...See details»
LIMERSTON CAPITAL BACKED CONCEPT LIFE …
Nov 4, 2024 UK-based drug discovery, development and manufacturing organisation, Concept Life Sciences (CLS), backed by mid-market private equity investment firm Limerston Capital, has completed the acquisition of …See details»
Charnwood Molecular’s journey from university spin …
Oct 12, 2021 Steve Allin co-founded Charnwood Molecular with Phil Page in 1998. 22 years later, the business has evolved dramatically from its origins as a spinout of Loughborough University. Backed by a partnership with Synova …See details»
Charnwood Molecular - LinkedIn
Charnwood Molecular | 6,527 followers on LinkedIn. for the discovery. | Integrated Drug Discovery – from target to candidate. Our collaborative approach and closely aligned teams across all scientific disciplines means that we offer a truly integrated drug discovery solution. Operating …See details»
Charnwood Molecular Ltd Announces Rebrand to Charnwood …
Sep 25, 2023 Charnwood Molecular, a leading drug discovery CRO that specializes in enhancing the experience and success of complex drug discovery for clients globally, is excited to announce a significant milestone in its history.Effective Thursday 21 September 2023, the …See details»
Charnwood Molecular - Products, Competitors, Financials, …
Charnwood Molecular is a contract research organization specializing in integrated drug discovery services within the pharmaceutical and biotechnology sectors. The company offers a suite of services including target validation, assay development, hit identification, lead optimization, …See details»
Charnwood Molecular - Funding, Financials, Valuation & Investors
Jun 21, 2021 Charnwood Molecular providing medicinal and synthetic chemistry services to the global pharmaceutical, biotechnology and chemical. New. Resources. Advanced Search. ... Which types of acquisition does this organization make most frequently? Show . Acquiree Name . …See details»
Charnwood Molecular - Craft
Charnwood Molecular is a contract research organization providing medicinal and synthetic chemistry services. Its offerings include medicinal chemistry, process research and chemical development, custom synthesis of building blocks and intermediates as well as route …See details»
CHARNWOOD MOLECULAR LIMITED - Companies House
Insolvency for CHARNWOOD MOLECULAR LIMITED (03550782) More for CHARNWOOD MOLECULAR LIMITED (03550782) Registered office address 8th Floor Central Square, 29 Wellington Street, Leeds, United Kingdom, LS1 4DL . Company status In Administration …See details»
Charnwood Molecular - Contacts, Employees, Board Members
Charnwood Molecular providing medicinal and synthetic chemistry services to the global pharmaceutical, biotechnology and chemical. ... Experience the new Crunchbase, powered by AI . Experience the new Crunchbase, powered by AI . Organization. Charnwood Molecular . …See details»
Charnwood Molecular - Medicines Discovery Catapult
Charnwood Molecular Excellence in Chemistry Operating from state-of-the-art facilities in Loughborough and BioCity, Nottingham, UK, Charnwood Molecular is an award-winning Contract Research Organisation providing synthetic chemistry services to the global pharmaceutical, …See details»
Life sciences firms alert administrators for second time
Oct 24, 2024 Charnwood Discovery’s latest accounts, made up to July 31 2023, show the company had a turnover of over £9.1m – up fron £8.8m in 2023. However, losses doubled to £4.9m from almost £2.4m in ...See details»
Charnwood Molecular chooses Charnwood Campus to accelerate …
Apr 28, 2021 Charnwood Molecular’s ambitious growth plans now see the company becoming the sole occupier of a substantial three-storey, state-of-the-art laboratory facility at Charnwood Campus. Recently designated a Life Sciences Opportunity Zone, Charnwood Campus …See details»
Charnwood Molecular unveils plans to quadruple capacity
Synova portfolio company, Charnwood Molecular, a leading UK-based outsourced drug discovery CRO servicing the global pharmaceutical and biotechnology market, has announced a milestone investment in its ambitious growth strategy.The company will become the sole occupier of a …See details»
CHARNWOOD MOLECULAR UNVEILS CUTTING EDGE …
In 2022 Charnwood Molecular relocated its BioCity and Loughborough operations to a single-site, state-of-the-art laboratory complex based in world-class facilities at Charnwood Campus, Loughborough. The campus was recently designated a “Life Sciences Opportunity Zone”, …See details»
Charnwood Molecular has moved to a single site from its previous ...
Apr 26, 2022 Charnwood Molecular said its investment in the site addressed a national need for specialist bio-chemistry facilities to drive potentially life-saving research into new drugs. The project was supported by £3.4 million from the Leicester and Leicestershire Enterprise …See details»
Charnwood Molecular Opens New Facilities in Loughborough
Apr 8, 2022 Charnwood Molecular, a UK-based pre-clinical discovery CRO serving the global pharmaceutical and biotechnology market, has opened its new facilities at Charnwood Campus, Loughborough. Charnwood Molecular has become the sole occupier of a three-story …See details»